```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4211 Introduced in House (IH)]

103d CONGRESS
  2d Session
                                H. R. 4211

   To provide for the coordination within the Federal Government of 
                biotechnology research and development.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 14, 1994

 Mr. Blute (for himself and Ms. Eshoo) introduced the following bill; 
which was referred jointly to the Committees on Energy and Commerce and 
                     Science, Space, and Technology

_______________________________________________________________________

                                 A BILL

 
   To provide for the coordination within the Federal Government of 
                biotechnology research and development.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Biotechnology Competitiveness Act of 
1994''.

SEC. 2. COORDINATION OF BIOTECHNOLOGY RESEARCH AND DEVELOPMENT.

    (a) Interagency Coordination.--The Director of the Office of 
Science and Technology Policy shall, in coordination with the heads of 
other Federal agencies that have substantial investment in the 
development and adoption of biotechnologies, take any action 
necessary--
            (1) to ensure, to the maximum extent practicable, the 
        coordinate, interagency promotion of the research, development, 
        and adoption of biotechnologies; and
            (2) to develop priorities for Federal biotechnology 
        research, development, and adoption efforts.
    (b) Implementation.--In carrying out this section, the Director of 
the Office of Science and Technology Policy shall--
            (1) review current Federally funded programs, including 
        Federal budget outlays for these programs, to determine their 
        role in the development and dissemination of biotechnologies;
            (2) coordinate with the relevant Federal agencies the 
        specific responsibilities of each appropriate Federal agency to 
        achieve the goals and priorities developed under this section;
            (3) calculate the levels of Federal funding required for 
        each Federal agency to carry out the specific responsibilities 
        determined in paragraph (2);
            (4) develop a means for ensuring, to the maximum extent 
        practicable, that the principles of sustainable economic 
        development are integrated into the research, development, and 
        technology programs of all Federal agencies;
            (5) ensure that the efforts of the Federal Government are 
        coordinated with the efforts of State and local governments and 
        private and nonprofit organizations promoting the research, 
        development, and demonstration of biotechnologies; and
            (6) submit to the Congress any recommendations regarding 
        legislative action, including recommendations on the roles of 
        Federal agencies, which may be required to carry out this 
        section.
    (c) Budget Coordination.--The Director of the Office of Science and 
Technology Policy shall annually assess, before the President submits 
to the Congress the budget for a fiscal year, the budget estimate of 
each relevant Federal agency for consistency with the plans, reviews, 
and priorities developed under this section. The Director shall make 
the results of the annual assessment available to the appropriate 
elements of the Executive Office of the President, particularly the 
Office of Management and Budget, for use in the preparation of such 
budget.
    (d) Annual Review and Plan.--The Director of the Office of Science 
and Technology shall annually submit to the Congress a report 
containing an evaluation and plan that assesses the progress of Federal 
efforts in advancing the research, development, and adoption of 
biotechnologies.
    (e) Non-Federal Participation.--The Director of the Office of 
Science and Technology shall establish mechanisms to ensure the 
participation of non-Federal entities, including State and local 
governments, United States industry, institutions of higher education, 
worker organizations, professional associations, and United States 
nonprofit organizations, in carrying out this section, including the 
development of the plans and reviews developed under this section.
    (f) Definition.--For purposes of this Act, the term 
``biotechnology'' means the application of engineering and 
technological principles to living organisms or their components to 
produce new inventions or processes.

                                 <all>
```